Boston Therapeutics, Inc.
BTHE · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$908 | -$3,694 | -$3,601 | -$1,585 |
| Dep. & Amort. | $1 | $150 | $160 | $67 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $145 | $175 | $50 |
| Change in WC | -$907 | -$3,935 | -$440 | -$3,050 |
| Other Non-Cash | $1,030 | $6,139 | $2,823 | $3,243 |
| Operating Cash Flow | -$784 | -$1,196 | -$884 | -$1,275 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$5 |
| Net Acquisitions | $0 | $0 | $4 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $4 | -$5 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $785 | $1,190 | $755 | $730 |
| Financing Cash Flow | $785 | $1,190 | $755 | $730 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1 | -$6 | -$125 | -$550 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7 | $12 | $137 | $687 |
| End Cash | $7 | $7 | $12 | $137 |
| Free Cash Flow | -$784 | -$1,196 | -$884 | -$1,280 |